GALECTIN-7-SPECIFIC MONOVALENT ANTIBODIES AND USES THEREOF
Monovalent antibodies such as nanobodies that are specific for galectin-7 are described. These monovalent antibodies are able to interfere with the dimerization of galectin-7, and thus may be used for the treatment of diseases associated with dysregulated galectin-7 expression and/or activity, such...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
16.07.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!